Position
Fidelity in Vaxcyte, Inc.
Back to the book · All holders of PCVX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $329.8K$58.11 → $58.13
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 13.8M | $638.3M | — | — | — | 0.0% |
| Q1 2026 | 16.5M | $958.4M | $58.11 | $165.6M | $154.5M | 0.1% |
| Q2 2026 | 20.9M | $1.21B | $58.13 | $329.8K | $253.4M | 0.1% |